Adaptate Biotherapeutics Ltd., of London, appointed Mihriban Tuna chief scientific officer, Mark Uden vice president pharmaceutical sciences, Oxana Polyakova head of discovery and Craig Taylor head of business operations.
Akcea Therapeutics Inc., of Boston, appointed Lisa Johnson-Pratt senior vice president of new product strategy and Joshua Patterson general counsel.
Horama SAS, of Paris, appointed Rodolphe Clerval chief business officer.
Precision Biosciences Inc., of Durham, N.C., appointed Geno Germano to its board.
Strand Therapeutics Inc., of Cambridge, Mass., appointed Dane Wittrup to its scientific advisory board and Mark Frohlich to its clinical advisory board.